WallStreetZenWallStreetZen

NASDAQ: AVIR
Atea Pharmaceuticals Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Atea Pharmaceuticals earnings were -$139.5M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest AVIR earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$34.3M, up 2.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, AVIR reported annual earnings of -$168.4M, with 23.9% growth.

AVIR earnings history

Current Revenue
$0.0
Current Earnings
-$139.5M
Current Profit Margin
0%

AVIR Return on Equity

Current Company
-31.3%
Current Industry
-60.2%
Current Market
31.4%
AVIR's Return on Equity (-31.3%)... subscribe to Premium to read more.
High Return on Equity Performance

AVIR undefined

Current Company
-29.3%
Current Industry
-2.5%
AVIR is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when AVIR announces earnings.

AVIR undefined

Current Company
-33.14%
Current Industry
5.8%
AVIR's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

AVIR vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
AVIR-$138.18M-$139.49MN/A-$1.65
ABEO-$36.93M-$44.19MN/A-$0.82
LXRX-$164.27M-$177.30MN/A-$0.51
IVA-$99.76M-$204.68MN/A-$3.42
BNTC-$24.79M-$27.11MN/A$0.00
View Top Biotech Stocks

Atea Pharmaceuticals Earnings Reports & History FAQ

What were Atea Pharmaceuticals's earnings last quarter?

Atea Pharmaceuticals (NASDAQ: AVIR) reported Q1 2025 earnings per share (EPS) of -$0.40, up 46.67% year over year. Total AVIR earnings for the quarter were -$34.27 million. In the same quarter last year, Atea Pharmaceuticals's earnings per share (EPS) was -$0.75.

If you're new to stock investing, here's how to buy Atea Pharmaceuticals stock.

Is Atea Pharmaceuticals profitable or losing money?

As of the last Atea Pharmaceuticals earnings report, Atea Pharmaceuticals is currently losing money. Atea Pharmaceuticals's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$139.49 million, a 14.77% decrease year over year.

What was AVIR's earnings growth in the past year?

As of Atea Pharmaceuticals's earnings date in Q2 2025, Atea Pharmaceuticals's earnings has grown year over year. AVIR earnings in the past year totalled -$139.49 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.